메뉴 건너뛰기




Volumn 128, Issue 8, 2018, Pages 729-735

The clinical significance of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in Guillain–Barré syndrome

Author keywords

GBS; immunity; inflammation; MLR; NLR

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

EID: 85047845894     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207454.2017.1418342     Document Type: Article
Times cited : (48)

References (32)
  • 1
    • 51449103646 scopus 로고    scopus 로고
    • Clinical features, pathogenesis, and treatment of Guillain–Barre syndrome
    • van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain–Barre syndrome. Lancet Neurol. 2008;7(10):939–950.
    • (2008) Lancet Neurol , vol.7 , Issue.10 , pp. 939-950
    • van Doorn, P.A.1    Ruts, L.2    Jacobs, B.C.3
  • 2
    • 79952724782 scopus 로고    scopus 로고
    • Population incidence of Guillain–Barre syndrome: a systematic review and meta-analysis
    • Sejvar JJ, Baughman AL, Wise M, et al. Population incidence of Guillain–Barre syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123–133.
    • (2011) Neuroepidemiology , vol.36 , Issue.2 , pp. 123-133
    • Sejvar, J.J.1    Baughman, A.L.2    Wise, M.3
  • 3
    • 33746533070 scopus 로고    scopus 로고
    • Infections and vaccinations preceding childhood Guillain–Barre syndrome: a prospective study
    • Schessl J, Luther B, Kirschner J, et al. Infections and vaccinations preceding childhood Guillain–Barre syndrome: a prospective study. Eur J Pediatr. 2006;165(9):605–612.
    • (2006) Eur J Pediatr , vol.165 , Issue.9 , pp. 605-612
    • Schessl, J.1    Luther, B.2    Kirschner, J.3
  • 4
    • 84883234295 scopus 로고    scopus 로고
    • Infectious and noninfectious triggers in Guillain–Barre syndrome
    • Wakerley BR, Yuki N. Infectious and noninfectious triggers in Guillain–Barre syndrome. Expert Rev Clin Immu. 2013;9(7):627–639.
    • (2013) Expert Rev Clin Immu , vol.9 , Issue.7 , pp. 627-639
    • Wakerley, B.R.1    Yuki, N.2
  • 5
    • 77953308800 scopus 로고    scopus 로고
    • Guillain–Barre syndrome (GBS)
    • Pithadia AB, Kakadia N. Guillain–Barre syndrome (GBS). Pharmacol Rep. 2010;62(2):220–232.
    • (2010) Pharmacol Rep. , vol.62 , Issue.2 , pp. 220-232
    • Pithadia, A.B.1    Kakadia, N.2
  • 6
    • 84897864453 scopus 로고    scopus 로고
    • Animal models of autoimmune neuropathy
    • Soliven B. Animal models of autoimmune neuropathy. ILAR J. 2014;54(3):282–290.
    • (2014) ILAR J. , vol.54 , Issue.3 , pp. 282-290
    • Soliven, B.1
  • 7
    • 84856112538 scopus 로고    scopus 로고
    • Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population
    • Imtiaz F, Shafique K, Mirza SS, et al. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med. 2012;5(1):2.
    • (2012) Int Arch Med , vol.5 , Issue.1 , pp. 2
    • Imtiaz, F.1    Shafique, K.2    Mirza, S.S.3
  • 8
    • 84898459065 scopus 로고    scopus 로고
    • CCR2 gene deletion and pharmacologic blockade ameliorate a severe murine experimental autoimmune neuritis model of Guillain–Barre syndrome
    • Yuan F, Yosef N, Lakshmana Reddy C, et al. CCR2 gene deletion and pharmacologic blockade ameliorate a severe murine experimental autoimmune neuritis model of Guillain–Barre syndrome. PloS One. 2014;9(3):e90463.
    • (2014) PloS One , vol.9 , Issue.3
    • Yuan, F.1    Yosef, N.2    Lakshmana Reddy, C.3
  • 9
    • 80755128486 scopus 로고    scopus 로고
    • A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study
    • Proctor MJ, Morrison DS, Talwar D, et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer. 2011;47(17):2633–2641.
    • (2011) Eur J Cancer , vol.47 , Issue.17 , pp. 2633-2641
    • Proctor, M.J.1    Morrison, D.S.2    Talwar, D.3
  • 10
    • 65549146877 scopus 로고    scopus 로고
    • Systemic inflammation, nutritional status and survival in patients with cancer
    • McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009;12(3):223–226.
    • (2009) Curr Opin Clin Nutr Metab Care , vol.12 , Issue.3 , pp. 223-226
    • McMillan, D.C.1
  • 12
    • 84865281097 scopus 로고    scopus 로고
    • The evaluation of neutrophil-lymphocyte ratio in Alzheimer's disease
    • Kuyumcu ME, Yesil Y, Ozturk ZA, et al. The evaluation of neutrophil-lymphocyte ratio in Alzheimer's disease. Dement Geriatr Cogn Disord. 2012;34(2):69–74.
    • (2012) Dement Geriatr Cogn Disord. , vol.34 , Issue.2 , pp. 69-74
    • Kuyumcu, M.E.1    Yesil, Y.2    Ozturk, Z.A.3
  • 13
    • 84878582775 scopus 로고    scopus 로고
    • Neutrophil lymphocyte ratios in stroke subtypes and transient ischemic attack
    • Gokhan S, Ozhasenekler A, Mansur Durgun H, et al. Neutrophil lymphocyte ratios in stroke subtypes and transient ischemic attack. Eur Rev Med Pharmacol Sci. 2013;17(5):653–657.
    • (2013) Eur Rev Med Pharmacol Sci , vol.17 , Issue.5 , pp. 653-657
    • Gokhan, S.1    Ozhasenekler, A.2    Mansur Durgun, H.3
  • 14
    • 84925482077 scopus 로고    scopus 로고
    • The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson's disease
    • Akil E, Bulut A, Kaplan I, et al. The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson's disease. Neurol Sci: Off J Italian Neurol Soc Italian Soc Clin Neurophysiol. 2015;36(3):423–428.
    • (2015) Neurol Sci: Off J Italian Neurol Soc Italian Soc Clin Neurophysiol , vol.36 , Issue.3 , pp. 423-428
    • Akil, E.1    Bulut, A.2    Kaplan, I.3
  • 15
    • 84938316818 scopus 로고    scopus 로고
    • The clinical significance of the neutrophil-to-lymphocyte ratio in multiple sclerosis
    • Demirci S, Demirci S, Kutluhan S, et al. The clinical significance of the neutrophil-to-lymphocyte ratio in multiple sclerosis. Int J Neurosci. 2016;126(8):700–706.
    • (2016) Int J Neurosci , vol.126 , Issue.8 , pp. 700-706
    • Demirci, S.1    Demirci, S.2    Kutluhan, S.3
  • 16
    • 84939619457 scopus 로고    scopus 로고
    • Use of the monocyte-to-lymphocyte ratio to predict diabetic retinopathy
    • Yue S, Zhang J, Wu J, et al. Use of the monocyte-to-lymphocyte ratio to predict diabetic retinopathy. Int J Environ Res Public Health. 2015;12(8):10009–10019.
    • (2015) Int J Environ Res Public Health , vol.12 , Issue.8 , pp. 10009-10019
    • Yue, S.1    Zhang, J.2    Wu, J.3
  • 17
    • 85006399734 scopus 로고    scopus 로고
    • Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever
    • Naess A, Nilssen SS, Mo R, et al. Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever. Infection. 2017;45(3):299–307.
    • (2017) Infection , vol.45 , Issue.3 , pp. 299-307
    • Naess, A.1    Nilssen, S.S.2    Mo, R.3
  • 18
    • 84992135108 scopus 로고    scopus 로고
    • Preoperative neutrophil-lymphocyte and lymphocyte-monocyte ratios reflect immune cell population rearrangement in resectable pancreatic cancer
    • Sierzega M, Lenart M, Rutkowska M, et al. Preoperative neutrophil-lymphocyte and lymphocyte-monocyte ratios reflect immune cell population rearrangement in resectable pancreatic cancer. Ann Surg Oncol. 2017;24(3):808–815.
    • (2017) Ann Surg Oncol , vol.24 , Issue.3 , pp. 808-815
    • Sierzega, M.1    Lenart, M.2    Rutkowska, M.3
  • 19
    • 84990041862 scopus 로고    scopus 로고
    • Analysis of the albumin level, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio in Guillain–Barre syndrome
    • Ozdemir HH. Analysis of the albumin level, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio in Guillain–Barre syndrome. Arquivos de neuro-psiquiatria. 2016;74(9):718–722.
    • (2016) Arquivos de neuro-psiquiatria , vol.74 , Issue.9 , pp. 718-722
    • Ozdemir, H.H.1
  • 20
    • 0035051829 scopus 로고    scopus 로고
    • Diagnostic and classification criteria for the Guillain–Barre syndrome
    • Van der Meche FG, Van Doorn PA, Meulstee J, et al. Diagnostic and classification criteria for the Guillain–Barre syndrome. Eur Neurol. 2001;45(3):133–139.
    • (2001) Eur Neurol , vol.45 , Issue.3 , pp. 133-139
    • Van der Meche, F.G.1    Van Doorn, P.A.2    Meulstee, J.3
  • 21
    • 0018119702 scopus 로고
    • Controlled trial prednisolone in acute polyneuropathy
    • Hughes RA, Newsom-Davis JM, Perkin GD, et al. Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978;2(8093):750–753.
    • (1978) Lancet , vol.2 , Issue.8093 , pp. 750-753
    • Hughes, R.A.1    Newsom-Davis, J.M.2    Perkin, G.D.3
  • 22
    • 84941309234 scopus 로고    scopus 로고
    • Subtypes and prognosis of Guillain–Barre syndrome in southwest China
    • Zhang G, Li Q, Zhang R, et al. Subtypes and prognosis of Guillain–Barre syndrome in southwest China. PloS One. 2015;10(7):e0133520.
    • (2015) PloS One , vol.10 , Issue.7
    • Zhang, G.1    Li, Q.2    Zhang, R.3
  • 23
    • 0034309069 scopus 로고    scopus 로고
    • Pain management for multiple sclerosis patients
    • Howarth AL. Pain management for multiple sclerosis patients. Prof Nurse. 2000;16(1):824–826.
    • (2000) Prof Nurse , vol.16 , Issue.1 , pp. 824-826
    • Howarth, A.L.1
  • 24
    • 61349195835 scopus 로고    scopus 로고
    • Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocycline
    • Zhang ZY, Zhang Z, Fauser U, et al. Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocycline. J Cell Mol Med. 2009;13(2):341–351.
    • (2009) J Cell Mol Med , vol.13 , Issue.2 , pp. 341-351
    • Zhang, Z.Y.1    Zhang, Z.2    Fauser, U.3
  • 25
    • 70349841590 scopus 로고    scopus 로고
    • Distribution of inducible nitric oxide synthase and tumor necrosis factor-alpha in the peripheral nervous system of Lewis rats during ascending paresis and spontaneous recovery from experimental autoimmune neuritis
    • De La Hoz CL, Castro FR, Santos LM, et al. Distribution of inducible nitric oxide synthase and tumor necrosis factor-alpha in the peripheral nervous system of Lewis rats during ascending paresis and spontaneous recovery from experimental autoimmune neuritis. Neuroimmunomodulation. 2010;17(1):56–66.
    • (2010) Neuroimmunomodulation , vol.17 , Issue.1 , pp. 56-66
    • De La Hoz, C.L.1    Castro, F.R.2    Santos, L.M.3
  • 26
    • 0142056076 scopus 로고    scopus 로고
    • Guillain–Barre syndrome with marked pleocytosis or a significant proportion of polymorphonuclear granulocytes in the cerebrospinal fluid: neuropathological investigation of five cases and review of differential diagnoses
    • Rauschka H, Jellinger K, Lassmann H, et al. Guillain–Barre syndrome with marked pleocytosis or a significant proportion of polymorphonuclear granulocytes in the cerebrospinal fluid: neuropathological investigation of five cases and review of differential diagnoses. Eur J Neurol. 2003;10(5):479–486.
    • (2003) Eur J Neurol , vol.10 , Issue.5 , pp. 479-486
    • Rauschka, H.1    Jellinger, K.2    Lassmann, H.3
  • 27
    • 0026746211 scopus 로고
    • Inflammatory mediators in demyelinating disorders of the CNS and PNS
    • Hartung HP, Jung S, Stoll G, et al. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J Neuroimmunol. 1992;40(2–3):197–210.
    • (1992) J Neuroimmunol , vol.40 , Issue.2-3 , pp. 197-210
    • Hartung, H.P.1    Jung, S.2    Stoll, G.3
  • 28
    • 0032054104 scopus 로고    scopus 로고
    • Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain–Barre syndrome
    • Zhu J, Mix E, Link H. Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain–Barre syndrome. J Neuroimmunol. 1998;84(1):40–52.
    • (1998) J Neuroimmunol , vol.84 , Issue.1 , pp. 40-52
    • Zhu, J.1    Mix, E.2    Link, H.3
  • 29
    • 0027160921 scopus 로고
    • Tumor necrosis factor-alpha in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system
    • Stoll G, Jung S, Jander S, et al. Tumor necrosis factor-alpha in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J Neuroimmunol. 1993;45(1–2):175–182.
    • (1993) J Neuroimmunol , vol.45 , Issue.1-2 , pp. 175-182
    • Stoll, G.1    Jung, S.2    Jander, S.3
  • 30
    • 0034237629 scopus 로고    scopus 로고
    • Tumour necrosis factor-alpha has few morphological effects within the dorsal columns of the spinal cord, in contrast to its effects in the peripheral nervous system
    • Hall SM, Redford EJ, Smith KJ. Tumour necrosis factor-alpha has few morphological effects within the dorsal columns of the spinal cord, in contrast to its effects in the peripheral nervous system. J Neuroimmunol. 2000;106(1–2):130–136.
    • (2000) J Neuroimmunol , vol.106 , Issue.1-2 , pp. 130-136
    • Hall, S.M.1    Redford, E.J.2    Smith, K.J.3
  • 31
    • 0034255882 scopus 로고    scopus 로고
    • The role of TNF-alpha during Wallerian degeneration
    • Liefner M, Siebert H, Sachse T, et al. The role of TNF-alpha during Wallerian degeneration. J Neuroimmunol. 2000;108(1–2):147–152.
    • (2000) J Neuroimmunol , vol.108 , Issue.1-2 , pp. 147-152
    • Liefner, M.1    Siebert, H.2    Sachse, T.3
  • 32
    • 30344481086 scopus 로고    scopus 로고
    • Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis
    • Mahad D, Callahan MK, Williams KA, et al. Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis. Brain: A J Neurol. 2006;129(Pt 1):212–223.
    • (2006) Brain: A J Neurol , vol.129 , pp. 212-223
    • Mahad, D.1    Callahan, M.K.2    Williams, K.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.